by GL Sciences
Inertsil ODS-4
The Most Deactivated Column Ever Made
GL Sciences’ newly-developed chemical bonding technology allows Inertsil ODS-4 to provide high efficiency and good peak shape where competitive columns fail. For example, in the examples at right, Inertsil ODS-4 is compared with competitive ODS phases for the analysis of basic and acidic compounds. Where other columns show poor peak shape, often with secondary interactions that result in prolonged retention, Inertsil ODS-4 delivers symmetric peaks with high efficiency.
Inertsil ODS-4 (and C8-4) is also available in 2 micron particle sizes for UHPLC.
| Vendor | GL Sciences | Max Pressure | 2900 |
| Brand | Inertsil ODS-4 | Surface Area | 450 |
| Modifification | Silica/C18 | Carbon Load, % | 11.0 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability from | 2.0 | |
| Internal Diameter | pH stability to | 7.5 | |
| Pore size | 100 |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Imtakt | Cadenza 5CL-C18 | Reversed-Phase | Silica/C18 | 3.0 mm | 75 mm | 5.0 μm | 120 Å | On request |
| Thermo Fisher Scientific | Aquasil | Reversed-Phase | Silica/C18 | 0.5 mm | 100 mm | 3.0 μm | 100 Å | On request |
| Bonna-Agela Technologies | Unisol C18 | Reversed-Phase | Silica/C18 | 3.0 mm | 100 mm | 5.0 μm | 100 Å | On request |
| Agilent Technologies | ZORBAX Stablebond | Reversed-Phase | Silica/C18 | 4.0 mm | 50 mm | 1.8 μm | 80 Å | On request |
| Sepax Technologies | Sepax Bio 300 C18 | Reversed-Phase | Silica/C18 | 0.1 mm | 150 mm | 5.0 μm | 300 Å | On request |
| Thermo Fisher Scientific | Acclaim | Reversed-Phase | Silica/C18 | 3.0 mm | 100 mm | 2.2 μm | 120 Å | On request |
| ACE | ACE UltraCore 5 Super C18 | Reversed-Phase | Silica/C18 | 3.0 mm | 50 mm | 5.0 μm | 95 Å | On request |
| Thermo Fisher Scientific | Acclaim | Reversed-Phase | Silica/C18 | 2.1 mm | 150 mm | 2.2 μm | 120 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
